MyRNA is pleased to announce that LUNGClear™, is now available on the SEHATi
MyRNA is pleased to announce that LUNGClear™, our blood-based lung cancer risk screening test, is now available on the SEHATi application by PERKESO, effective 13 April 2026.
Built on the principle of “precision diagnostics, made just in time,” LUNGClear™ is designed to enable earlier, more informed health decisions—before symptoms appear and when intervention can be most impactful.
This integration expands access to early lung cancer risk assessment through Malaysia’s growing digital healthcare ecosystem, enabling users to conveniently book screenings at SEHATi panel clinics.
Supporting Earlier Detection
Lung cancer remains one of the leading causes of cancer-related deaths in Malaysia, with most cases diagnosed at advanced stages. With fewer than 1 in 10 patients surviving beyond five years, early risk identification plays a critical role in improving outcomes.
LUNGClear™ addresses this need by providing a simple, non-invasive blood test that helps identify individuals at risk—supporting timely follow-up and clinical decision-making.
How It Works
The screening involves a routine blood draw at a SEHATi panel clinic, using two ethylenediaminetetraacetic acid (EDTA) tubes. Samples are analysed to generate a personalised risk score, with results available within 7 working days. No fasting or special preparation is required.
Access via SEHATi
LUNGClear™ is currently available at more than 1,300 SEHATi panel clinics across the Klang Valley, with plans to expand nationwide.
Users can book the screening through the SEHATi app under the Marketplace section:
Health Screening / Cancer Screening → LUNGClear™ → Select clinic → Complete booking.
The test is available:
RM420 as an add-on to PERKESO’s Health Screening Package
RM480 as a standalone screening
Moving Preventive Care Forward
The availability of LUNGClear™ on SEHATi reflects a shared commitment to improving access to preventive healthcare and early detection in Malaysia. By combining innovative diagnostics with digital access, MyRNA continues to support better health outcomes through earlier intervention—delivering precision diagnostics exactly when they are needed most.
👉 For more information, visit www.myrna.my
